Stock Comparison

TXG vs VEEV

10X Genomics Inc and Veeva Systems Inc Class A side by side — valuation, profitability, growth and risk.

TXG

10X Genomics Inc

Healthcare

VEEV

Veeva Systems Inc Class A

Healthcare

Valuation

Market Cap

$4.67B

$27.84B

P/E (TTM)

—

30.4

Forward P/E

625.0

19.1

Price/Sales

7.3

8.4

Price/Book

5.7

3.8

EV/EBITDA

112.1

20.7

Dividend Yield

—

Profitability

Net Margin

-3.55%

28.40%

Operating Margin

-11.30%

30.90%

Return on Equity

-2.98%

13.90%

Return on Assets

-4.48%

7.30%

Growth (YoY)

Revenue Growth

-2.60%

16.30%

Earnings Growth

0.00%

14.60%

Price & Risk

Beta

2.1

0.9

52-Week High

$37.05

$310.50

52-Week Low

$11.16

$148.05

Analyst Target

$27.62

$244.59

Compare TXG and VEEV your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.